(2-oxo-2H-benzo[h]chromen-4-yl)acetic acid, 95.0%, 1g

(R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-methoxyphenyl)propanoic acid, 97%, 1g

8-Bromo-1,2,3,4-tetrahydroisoquinoline hydrochloride, 95.0%, 250mg

Ethyl 4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxylate, 95.0%, 500mg

N-(3-Chloro-4-fluorophenyl)-7-(3-morpholinopropoxy)-6-nitroquinazolin-4-amine, 95.0%, 100mg

(E)-Ethyl 2-cyano-3-(4-hydroxyphenyl)acrylate, 95.0%, 1g

TERT-BUTYL 2-(2-(HYDROXYMETHYL)PIPERIDIN-1-YL)ACETATE, 95.0%, 1g

Fmoc-R-3-amino-4-(3,5-difluorophenyl)-butyric acid, 97%, 5g

Setaccio di prova Ø 200 mm, 37,5 mm, 1 Pezzo(i)

ethyl 1-(2,2,2-trifluoroethyl)-1H-pyrazole-3-carboxylate, 97%, 2.5g

ACETYLAMINO-CYCLOPENTYL-ACETIC ACID, 97.0%, 250mg

(1R,2R)-1,2-Cyclohexanedimethanol>98.0%(GC)1g

Aprocitentan, 100mg